Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BHST vs BLNE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BHST Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 6–4 Matrix Metrics)

BHST Overall Winner 6-Pillar Tally: BHST 5 – 1 BLNE Matrix Metrics: BHST 6 – 4 BLNE

As of Nov 20, 2026, BioHarvest Sciences Inc. (BHST) is the stronger overall head-to-head candidate over Beeline Holdings, Inc. (BLNE) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). BHST carries a Unified Composite Score of 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin), whereas BLNE carries 43.4/100 (HOLD) at $0.29 (5.5x Forward P/E, -179.8% operating margin).

  • Growth vs. Quality Trade-Off: BHST earns the overall head-to-head edge with a stronger Unified Composite Score (58.2/100 HOLD vs. BLNE 43.4/100 HOLD) and 0.25β · 86% Vol risk profile, whereas BLNE leads top-line expansion (+29.8% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: BHST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2); meanwhile BLNE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 19.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BHST vs BLNE
BHST NASDAQ Head-to-Head Winner
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
TTM Revenue $35M
Forward P/E N/M
Beta / 30D Vol 0.25β · 86% Vol
Unified Composite Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 37
RSI-14: 37.2 · SMA20: $1.55 · SMA50: $1.58
BLNE NASDAQ
Beeline Holdings, Inc. Common Stock
Mortgage Bankers & Loan Correspondents
$0.29
-21.72% 1D
Market Cap $13.1M
TTM Revenue $12M
Forward P/E 5.5x
Beta / 30D Vol 2.74β · 123% Vol
Unified Composite Score
43.4 / 100 HOLD
Tech 25.0 Fund 42.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -19.6%), weak momentum, RSI 19
RSI-14: 19.1 · SMA20: $0.57 · SMA50: $0.73

6-Pillar Scorecard Institutional Category Breakdown (BHST 5 – 1 BLNE)

Columns: Metric · BHST · BLNE
1. Valuation Multiples BLNE
Forward P/E N/M 5.5x
Trailing P/E N/M 5.5x
PEG Ratio N/M N/M
EV / Revenue 0.7x 2.5x
2. Growth & Scale BHST
Revenue Growth (YoY) +3.8% +29.8%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $35M $12M
Market Cap $29.9M $13.1M
3. Profitability & Quality BHST
Gross Margin 59.0% 100.0%
Operating Margin -18.0% -179.8%
Net Profit Margin -31.2% -185.9%
Return on Equity (ROE) -142.5% -42.4%
4. Balance Sheet & Cash Flow BHST
Cash Generation (TTM) -$9.4M -$24M
Cash Flow Margin -26.6% N/A
Net Cash / Leverage $5.1M Net Cash $15M Net Debt (0.34x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning BHST
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat BHST
OpEx & R&D Intensity 77.0% of Rev ($27M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Packaged Foods Operator Mortgage Finance Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BHST (6) vs BLNE (4)
Institutional Metric BHST BLNE Criterion Row Edge
Market Capitalization
Scale
$29.9M $13.1M Larger Scale BHST
Trailing P/E Ratio
Valuation
N/M 5.5x Lower Multiple BLNE
Forward P/E Ratio
Valuation
N/M 5.5x Lower Multiple BLNE
Revenue Growth (YoY)
Growth
+3.8% +29.8% Higher Growth BLNE
Operating Margin (TTM)
Profitability
-18.0% -179.8% Higher Margin BHST
Net Profit Margin
Profitability
-31.2% -185.9% Higher Margin BHST
Return on Equity (ROE)
Capital Efficiency
-142.5% -42.4% Higher ROE BLNE
52-Week Range Position
Momentum
6% ($1–$7) 0% ($0–$4) Stronger Trend BHST
Beta / 30D Volatility
Risk Regime
0.25β · 86% Vol 2.74β · 123% Vol Lower Realized Risk BHST
Unified Institutional Score
Composite Signal
58.2 / 100 (HOLD) 43.4 / 100 (HOLD) Higher Composite BHST
Trailing 12M Revenue (USD)
Operating Scale
$35M $12M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
59.0% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.7x EV/Rev N/M PEG · 2.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$9.4M ($5.1M Net Cash) -$24M ($15M Net Debt (0.34x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BHST +34.89 pp
BHST: -22.62% · BLNE: -57.51%
3M Horizon BHST +33.9 pp
BHST: -36.59% · BLNE: -70.49%
6M Horizon BHST +9.13 pp
BHST: -66.32% · BLNE: -75.45%
1Y Horizon BHST +1.41 pp
BHST: -79.4% · BLNE: -80.81%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period BHST Revenue BLNE Revenue BHST Op. Margin BLNE Op. Margin Margin Leader
FY2018 N/A $10M N/A -114.7% BLNE
FY2019 N/A $10M N/A -81.6% BLNE
FY2020 N/A $10M N/A -55.4% BLNE
FY2021 N/A $10M N/A -55.7% BLNE
FY2022 N/A $10M N/A -47.9% BLNE
FY2023 $10M $10M -78.6% -23.1% BLNE
FY2024 $30M $0M -27.7% -467.0% BHST
FY2025 $30M $10M -16.2% -251.5% BHST

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BHST UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BLNE BREAKDOWN
102d in phase · OBV DISTRIBUTION
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact BLNE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BHST Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $29.9M market capitalization and -18.0% operating margin.
OpEx & R&D Reinvestment 77.0% of Rev ($27M)
90D Engineering Disclosures 0 Published
BLNE Moat Profile Cyclical / Execution-Driven Positioning
Mortgage Finance Operator
Competes within the Mortgage Finance value chain with $13.1M market capitalization and -179.8% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ BHST vs BLNE Key Questions & Quantitative Answers

As of Nov 20, 2026, BioHarvest Sciences Inc. (BHST) is the stronger overall head-to-head candidate over Beeline Holdings, Inc. (BLNE) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). BHST carries a Unified Composite Score of 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin), whereas BLNE carries 43.4/100 (HOLD) at $0.29 (5.5x Forward P/E, -179.8% operating margin). Growth vs. Quality Trade-Off: BHST earns the overall head-to-head edge with a stronger Unified Composite Score (58.2/100 HOLD vs. BLNE 43.4/100 HOLD) and 0.25β · 86% Vol risk profile, whereas BLNE leads top-line expansion (+29.8% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: BHST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2); meanwhile BLNE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 19.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BHST leads the Growth & Scale pillar: BHST posts +3.8% YoY revenue growth and +0.0% YoY earnings growth on $35M TTM revenue (59.0% gross margin, -18.0% operating margin), compared with BLNE at +29.8% YoY revenue growth and +0.0% YoY earnings growth on $12M TTM revenue (100.0% gross margin, -179.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), BHST cumulative revenue shifted +200.0% while BLNE shifted +0.0%. In operating R&D and SG&A reinvestment, BHST deploys 77.0% of Rev ($27M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BLNE.

BLNE screens cheaper on headline valuation multiples. BHST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-26.6% FCF margin), whereas BLNE trades at 5.5x Forward P/E, 5.5x Trailing P/E, N/M PEG, and 2.5x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BHST (-142.5% ROE) versus BLNE (-42.4% ROE) capital efficiency.

In options market volatility and institutional positioning, BHST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.25β · 86% Vol realized risk). By comparison, BLNE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.74β · 123% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.